ALT

News Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

14d ago

News Why Altimmune Was Such a Robustly Healthy Stock on Thursday

14d ago

News Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? - The Motley Fool

14d ago

News Altimmune outlines PERFORMA Phase III MASH start in 2H 2026 and cash runway to 2029 52-week readout

19d ago

SEC filing ALT Reports Q1 2026 Net Loss of $22.6M, $0.18 Loss per Share

20d ago

News Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

36d ago

Short interest Short interest 22.5% of float

38d ago

SEC filing ALT Announces $211.2M Offering: 64.25M Shares @ $3.00, 10.75M Pre-Funded Warrants @ $2.999, Net Proceeds $211.2M for MASH Phase 3, Pre-Commercial, Corporate Use

38d ago

News Altimmune prices $225M public offering of securities

40d ago

News Altimmune launches proposed public offering to fund late-stage trial

40d ago

Insider trade Purchase by Gregory L Weaver (Chief Financial Officer)

85d ago

Insider trade Purchase by Jerome Benedict Durso (President and CEO)

85d ago

News Altimmune outlines 1,800-patient Phase III MASH trial and signals cash runway into 2028 as pemvidutide advances

88d ago

News Altimmune to start late-stage trial for MASH candidate this year

89d ago

SEC filing ALT Reports $274M Cash, $75M Offering, FDA Breakthrough in MASH, Phase 3 2026, RECLAIM Data Q3

89d ago

News Earnings week ahead: AVGO, CRWD, PLUG, COST, TGT, MRVL, JD, KR, and more

93d ago

SEC filing Other Events

118d ago

News Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock

123d ago

SEC filing ALT Raises $75M in Registered Direct Offering, Sells 17M Shares and Warrants

124d ago

News Altimmune prices $75M direct offering

125d ago

News Mid to low cap healthcare stocks with the strongest earnings momentum

136d ago

News Altimmune gains on FDA breakthrough designation for MASH therapy

148d ago

News ALT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune

153d ago

Scanner Unusual volume (z=9.5)

160d ago

Scanner Unusual volume (z=9.0)

162d ago